Company is in the process to be listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars

TEL AVIV, Israel, June 18, 2024 /CNW/ — Zero Candida (the “Company” or “ZC “) an Israeli FemTech medical device start-up is pleased to announce its first INTELLECTUAL PROPERTY – 2022/09265 Granted + PCT patent PCT-IL 2023050243 in South Africa.